SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-06-015550
Filing Date
2006-12-22
Accepted
2006-12-22 16:00:53
Documents
5
Period of Report
2006-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y28268e8vk.htm 8-K 17821
2 EX-99.1: LEASE y28268exv99w1.htm EX-99.1 1044843
3 EX-99.2: CERTIFICATE OF AMENDMENT OF COMPANY'S RESTATED CERTIFICATE OF INCORPORA y28268exv99w2.htm EX-99.2 5918
4 EX-99.3: PRESS RELEASE y28268exv99w3.htm EX-99.3 5978
5 EX-99.4: PRESS RELEASE y28268exv99w4.htm EX-99.4 11057
  Complete submission text file 0000950123-06-015550.txt   1087157
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 061297138
SIC: 2834 Pharmaceutical Preparations